Form 4: National Healthcare Corp Director Exercises Stock Options
SEC Form 4
Director Ernest G. Burgess III exercised stock options to purchase 2,000 shares of National Healthcare Corp (NHC) common stock at $64.64 per share on February 27, 2024.
Summary
- On February 27, 2024, Ernest G. Burgess III, a director of National Healthcare Corp (NHC), exercised options to purchase 2,000 shares of common stock at a price of $64.64 per share.
- These options were granted on May 7, 2020, under the 2020 Omnibus Equity Incentive Plan.
- Following the transaction, Burgess directly owns 5,500 options from the 2020 grant and indirectly owns 85,000 shares of common stock held in the BTCP Trust, where he serves as trustee.
- Burgess also holds options to purchase 7,500 shares each from grants in 2019, 2021, 2022 and 2023.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing detailing a stock option exercise. It doesn't contain overtly positive or negative information, hence a neutral sentiment score.
Positives
- The exercise of stock options by a director could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
Stock option exercises are a common part of executive compensation in the healthcare industry, aligning management's interests with those of shareholders.
Comparison to Industry Standards
- Executive compensation packages, including stock options, are common in publicly traded healthcare companies like Brookdale Senior Living, Five Star Senior Living, and Life Care Centers of America.
- The specific terms of option grants (exercise price, vesting schedule, expiration date) are typically benchmarked against industry peers to attract and retain talent.
Stakeholder Impact
- The exercise of stock options could have a minor dilutive effect on existing shareholders, but it also aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/09/2019 | Date of option grant with an exercise price of $77.92 and an expiration date of 05/08/2024 for 7,500 shares. |
| 05/07/2020 | Date of option grant with an exercise price of $64.64 and an expiration date of 05/06/2025 for 7,500 shares. |
| 05/07/2020 | Date the exercised stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan. |
| 05/06/2021 | Date of option grant with an exercise price of $71.64 and an expiration date of 05/05/2026 for 7,500 shares. |
| 05/05/2022 | Date of option grant with an exercise price of $69.19 and an expiration date of 05/04/2027 for 7,500 shares. |
| 05/04/2023 | Date of option grant with an exercise price of $55.75 and an expiration date of 05/03/2028 for 7,500 shares. |
| 02/27/2024 | Date of the transaction: Director Ernest G. Burgess III exercised stock options. |
| 02/28/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.